Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
| Brand name | GABAPENTIN |
| Generic name | GABAPENTIN |
| Active ingredient(s) | GABAPENTIN |
| Distributed by / for | Northstar Rx LLC, Memphis, TN 38141; |
| NDC | 16714-662-01 |
| Full product label | Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5. |
| Recalling firm | Aurobindo Pharma USA Inc |
| Distribution | Nationwide |
| Quantity | 24,816 bottles |
| Recall initiated | 2014-10-17 |
| Report date | 2015-01-14 |
| Recall completed | 2016-05-23 |
| Recall number | D-0330-2015 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dayton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗